Submission supported by positive results from global, Phase 3 4WHIM clinical trial;U.S. regulatory approval in WHIM syndrome granted in ...

Millions of Brits have been warned to stay away from one particular fruit, as studies suggest it could pose a risk to the ...

According to the National Capital Poison Center, a not-for-profit poison control organization, at least 85 drugs—including ...

Rigel Pharmaceuticals, Inc.  today announced the first patient has been enrolled in a Phase 1 study evaluating the safety and tolerability of escalating doses of fostamatinib, the company's oral ...

While the fruit has many benefits, avoid eating it to prevent putting your health at risk if you take the medication ...

The NHS specifically warns patients taking selective serotonin reuptake inhibitors (SSRIs) and serotonin-noradrenaline ...

Millions of Brits are being warned to avoid a specific fruit, and there's an important reason behind this advice. Figures ...

如果 CYP3A4 酶的活性被抑制，会导致这些药物在体内的代谢减少，使药物在血液中的浓度升高，从而增强药物的作用和副作用，可能对人体造成损害。 不同的药物受到的影响不尽相同。但总体来说，呋喃香豆素可以使药物以 2～10 倍的量进入血液。

柚子如果吃错了，在某些情况下确实存在猝死的风险，这主要与柚子中的某些化学成分与药物的相互作用有关。 柚子与药物的相互作用 ...

Zytiga 的作用原理是减少体内雄激素的产生。雄激素是一种可以促进前列腺肿瘤生长的男性荷尔蒙。Zytiga 与类固醇药物（泼尼松或甲基泼尼松龙）一起使用，用于治疗已扩散到身体其他部位的前列腺癌。Zytiga ...

Drug Interactions: CAPLYTA ® should not be used with CYP3A4 inducers. Dose reduction is recommended for concomitant use with strong CYP3A4 inhibitors or moderate CYP3A4 inhibitors. Special Populations ...

In 2022, the FDA approved two new dosage strengths of Caplyta, 10.5 mg and 21 mg for patients concomitantly taking strong or moderate CYP3A4 inhibitors and 21 mg for patients with moderate or ...